Free Trial

New Age Alpha Advisors LLC Has $1.96 Million Position in HealthEquity, Inc. (NASDAQ:HQY)

HealthEquity logo with Medical background

Key Points

  • New Age Alpha Advisors LLC significantly increased its stake in HealthEquity, acquiring a total of 22,175 shares, worth approximately $1.96 million after purchasing an additional 19,584 shares in Q1.
  • HealthEquity reported earnings per share of $0.97, exceeding analysts' expectations of $0.81, and generated a revenue of $330.80 million in its most recent quarter.
  • Analysts have a consensus rating of "Buy" for HealthEquity, with price targets ranging from $100.00 to $120.00, indicating optimism for the company's stock performance.
  • Looking to export and analyze HealthEquity data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

New Age Alpha Advisors LLC boosted its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 755.8% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 22,175 shares of the company's stock after purchasing an additional 19,584 shares during the period. New Age Alpha Advisors LLC's holdings in HealthEquity were worth $1,960,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Versant Capital Management Inc acquired a new stake in shares of HealthEquity during the 1st quarter valued at $28,000. Transce3nd LLC acquired a new stake in shares of HealthEquity during the 4th quarter valued at $29,000. Larson Financial Group LLC lifted its position in shares of HealthEquity by 1,366.0% during the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock valued at $61,000 after acquiring an additional 642 shares during the last quarter. Whipplewood Advisors LLC lifted its position in shares of HealthEquity by 5,060.0% during the 1st quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock valued at $68,000 after acquiring an additional 759 shares during the last quarter. Finally, UMB Bank n.a. lifted its position in shares of HealthEquity by 104.8% during the 1st quarter. UMB Bank n.a. now owns 848 shares of the company's stock valued at $75,000 after acquiring an additional 434 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HQY has been the subject of a number of recent research reports. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. The Goldman Sachs Group increased their price objective on HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a research report on Wednesday, June 4th. Royal Bank Of Canada increased their price objective on HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a research report on Wednesday, June 4th. Bank of America boosted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a research note on Wednesday, June 4th. Finally, Raymond James Financial reissued a "strong-buy" rating and set a $120.00 target price (up from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Buy" and an average price target of $118.55.

Check Out Our Latest Stock Analysis on HealthEquity

HealthEquity Stock Up 0.1%

HealthEquity stock traded up $0.05 during mid-day trading on Monday, hitting $93.10. 57,018 shares of the company's stock were exchanged, compared to its average volume of 1,010,672. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. The stock has a market cap of $8.05 billion, a P/E ratio of 68.12, a P/E/G ratio of 1.44 and a beta of 0.54. HealthEquity, Inc. has a 1-year low of $69.52 and a 1-year high of $116.65. The stock has a 50 day moving average of $100.26 and a two-hundred day moving average of $97.78.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The company had revenue of $330.80 million during the quarter, compared to analysts' expectations of $322.25 million. During the same period in the prior year, the company earned $0.80 earnings per share. As a group, analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Jon Kessler sold 134,183 shares of the stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.08, for a total value of $15,039,230.64. Following the completion of the transaction, the director owned 253,510 shares of the company's stock, valued at $28,413,400.80. This represents a 34.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Elimelech Rosner sold 58,000 shares of the stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the completion of the transaction, the executive vice president directly owned 75,689 shares of the company's stock, valued at $8,519,553.84. This trade represents a 43.38% decrease in their position. The disclosure for this sale can be found here. Insiders sold 291,744 shares of company stock valued at $32,705,007 over the last quarter. Corporate insiders own 1.50% of the company's stock.

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

See Also

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines